Yonghui Sun

Prof. Dr. Yonghui Sun

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2024 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YSYonghui Sun
Yonghui Sun
XLXiao Liu
Xiao Liu
HYHe qi Yu
He qi Yu
NZNaizhen Zhang
Naizhen Zhang
WYWei Yan
Wei Yan
YWYanjie Wang
Yanjie Wang
Maternal embryonic leucine zipper kinase (MELK) is a novel target for the treatment of various kinds of B-cell malignancies. However, the toxicity of inhibitors of MELK has led to clinical failures in cancer treatments. Moreover, inactivation of MELK catalytic domain is insufficient for achieving cancer cell apoptosis. To further confirm the role of MELK in Burkitt lymphoma treatment, we describe herein a structure-guided design of PROTACs targeting MELK. Through design, computer-assisted optimization and SAR studies, we developed the first-in-class MELK-targeting PROTAC MGP-39, which promoted a rapid and potent degradation of MELK in RAMOS cells. Additionally, the newly designed MELK degrader induced significant cell cycle arrest and apoptosis in cancer cells. Notably, compared to MELK inhibitors, MGP-39 has better anti-cancer activity and lower toxicity, indicating the practical role of PROTACs in avoiding the side effects of traditional inhibitors. More importantly, our results show that the use of a PROTAC can be adopted as a general and effective strategy for targeted cancer therapy.

16 June 2024 in Molecules
Verified
Journal Article
Open access
PDF file
YSYonghui Sun
Yonghui Sun
HYHe qi Yu
He qi Yu
XLXucheng Lv
Xucheng Lv
NZNaizhen Zhang
Naizhen Zhang
WYWei Yan
Wei Yan
LZLili Zhuang
Lili Zhuang
Regioselective benzanilide bromination that generates either regioisomer from the same starting material is desirable. Herein, we develop switchable site-selective C(sp2)-H bromination by promoter regulation. This protocol leads to regiodivergent brominated benzanilide starting from the single substrate via selection of promoters. The protocol demonstrates excellent regioselectivity and good tolerance of functional groups with high yields. The utility effectiveness of this method has been well exemplified in the late-stage modification of biologically important molecules.

5 November 2025 in Chinese Chemical Letters
Verified
Journal Article
Closed access
WYWei Yan
Wei Yan
NZNaizhen Zhang
Naizhen Zhang
XLXiao Liu
Xiao Liu
HYHe qi Yu
He qi Yu
XLXucheng Lv
Xucheng Lv
YSYonghui Sun
Yonghui Sun